IL139432A0 - Modifying the expression of the fsh beta gene by homologous recombination - Google Patents

Modifying the expression of the fsh beta gene by homologous recombination

Info

Publication number
IL139432A0
IL139432A0 IL13943299A IL13943299A IL139432A0 IL 139432 A0 IL139432 A0 IL 139432A0 IL 13943299 A IL13943299 A IL 13943299A IL 13943299 A IL13943299 A IL 13943299A IL 139432 A0 IL139432 A0 IL 139432A0
Authority
IL
Israel
Prior art keywords
modifying
expression
homologous recombination
beta gene
fsh beta
Prior art date
Application number
IL13943299A
Other languages
English (en)
Original Assignee
Transkaryotic Therapies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transkaryotic Therapies Inc filed Critical Transkaryotic Therapies Inc
Publication of IL139432A0 publication Critical patent/IL139432A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13943299A 1998-05-07 1999-05-05 Modifying the expression of the fsh beta gene by homologous recombination IL139432A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8466398P 1998-05-07 1998-05-07
PCT/US1999/009795 WO1999057263A1 (en) 1998-05-07 1999-05-05 Modifying the expression of the fsh beta gene by homologous recombination

Publications (1)

Publication Number Publication Date
IL139432A0 true IL139432A0 (en) 2001-11-25

Family

ID=22186422

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13943299A IL139432A0 (en) 1998-05-07 1999-05-05 Modifying the expression of the fsh beta gene by homologous recombination

Country Status (18)

Country Link
US (2) US6200778B1 (no)
EP (1) EP1075514A1 (no)
JP (1) JP2002513566A (no)
KR (1) KR20010052279A (no)
CN (1) CN1308673A (no)
AR (1) AR016262A1 (no)
AU (1) AU766620B2 (no)
CA (1) CA2328506A1 (no)
CZ (1) CZ299611B6 (no)
HU (1) HUP0101961A3 (no)
IL (1) IL139432A0 (no)
NO (1) NO20005587L (no)
NZ (1) NZ507459A (no)
PL (1) PL343732A1 (no)
RU (1) RU2229309C2 (no)
TW (1) TWI225517B (no)
WO (1) WO1999057263A1 (no)
ZA (1) ZA200005746B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548296B1 (en) 1997-07-23 2003-04-15 Roche Diagnostics Gmbh Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof
US6897066B1 (en) * 1997-09-26 2005-05-24 Athersys, Inc. Compositions and methods for non-targeted activation of endogenous genes
AU1647501A (en) 1999-12-10 2001-06-18 Cytos Biotechnology Ag Replicon based activation of endogenous genes
JP2002017357A (ja) * 2000-07-04 2002-01-22 Calpis Co Ltd アンカーペプチド、融合蛋白質、及び蛋白質の固定化方法
ES2367257T3 (es) 2002-04-25 2011-10-31 Shire Human Genetic Therapies, Inc. Tratamiento de deficit de alfa-galactosidasa a.
AU2003296438A1 (en) * 2002-12-24 2004-07-29 North Carolina State University Increasing gamete production with a gene switch
KR100533794B1 (ko) * 2003-10-02 2005-12-07 주식회사 프로젠 인간 난포자극 호르몬을 대량으로 생산하는 방법
PT2137655E (pt) 2007-04-16 2012-09-14 Momenta Pharmaceuticals Inc Produtos de glicoproteína definidos e métodos relacionados
CN101397339B (zh) * 2008-09-24 2012-07-25 上海天伟生物制药有限公司 糖蛋白中去除/灭活病毒的方法
EP2325194A1 (en) 2009-11-24 2011-05-25 Glycotope GmbH Process for the purification of glycoproteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639639A (en) * 1983-11-02 1997-06-17 Genzyme Corporation Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
US5272071A (en) * 1989-12-22 1993-12-21 Applied Research Systems Ars Holding N.V. Method for the modification of the expression characteristics of an endogenous gene of a given cell line
US5968502A (en) 1991-11-05 1999-10-19 Transkaryotic Therapies, Inc. Protein production and protein delivery
US5641670A (en) * 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery

Also Published As

Publication number Publication date
PL343732A1 (en) 2001-09-10
KR20010052279A (ko) 2001-06-25
HUP0101961A2 (hu) 2001-10-28
NO20005587L (no) 2001-01-03
EP1075514A1 (en) 2001-02-14
AU766620B2 (en) 2003-10-23
AU3881799A (en) 1999-11-23
NZ507459A (en) 2004-01-30
CA2328506A1 (en) 1999-11-11
TWI225517B (en) 2004-12-21
AR016262A1 (es) 2001-06-20
ZA200005746B (en) 2001-05-17
RU2229309C2 (ru) 2004-05-27
US6200778B1 (en) 2001-03-13
WO1999057263A1 (en) 1999-11-11
CZ20003773A3 (cs) 2001-04-11
US20010034044A1 (en) 2001-10-25
HUP0101961A3 (en) 2003-08-28
WO1999057263A9 (en) 2000-03-02
CN1308673A (zh) 2001-08-15
JP2002513566A (ja) 2002-05-14
NO20005587D0 (no) 2000-11-06
CZ299611B6 (cs) 2008-09-17

Similar Documents

Publication Publication Date Title
PT2944695T (pt) Novas construções de expressão vegetais
PL346650A1 (en) Plant expression vectors
EP1027473A4 (en) MINIATURIZED ROOM FOR BATCH PROCESSING
HK1091212A1 (en) Nucleotide analog compositions
ZA981574B (en) Hard-surface cleaning compositions.
PL343732A1 (en) Modifying the expression of the fsh beta gene by homologous recombination
GB2337367B (en) Elongated tubular product, especially of the installation duct type
GB9719727D0 (en) New plant genes
EP1222212A4 (en) MUTANTS OF IL-13
AU2422999A (en) New members of the glypican gene family
AU6277600A (en) Novel chimeric genes
PL354293A1 (en) Plant seed endosperm-specific promoter
SI0996430T1 (en) Nucleotide analog compositions
GB9920816D0 (en) Plant gene
AU2867299A (en) Fast single-article megasonic cleaning process
AU6229800A (en) Conditional homologous recombination of large genomic vector inserts
GB9917109D0 (en) Plant genes
AU4513599A (en) Nucleotide sequence
AU5235298A (en) Beehive feeder
GB9915540D0 (en) Root feeder
GB2346792B (en) Bird feeder
SG87805A1 (en) Beta, gamma-unsaturated delta-keto esters
AU5873399A (en) Plant promoter
EP1182256A4 (en) WITH POLLINOSIS ASSOCIATED GEN 513
AU2002300590A1 (en) Sequence alterations using homologous recombination